Brief: Moberg Pharma Q2 Oper Loss At SEK 9.7 Mln
Aug 12 (Reuters) - Moberg Pharma AB (publ) MBPH.ST: Q2 EBITDA SEK -9.3 MILLION (-5.2) Q2 OPERATING PROFIT (EBIT) SEK -9.7 MILLION (-5.5) Q2 NET REVENUE SEK 3.6 MILLION (4.1) Source text: ID:nWkr2V4gsc Further company coverage: MBPH.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Moberg Pharma AB (publ)
See all newsSweden's Moberg Pharma Q2 loss narrows as revenue rises
Brief: Moberg Pharma Q2 EBITDA SEK -4.3 Million
Brief: Moberg Pharma Names Vaidrius Navikas Chief Medical Officer
Brief: Moberg Pharma And Karo Healthcare Expand Collaboration
Moberg Pharma Q1 revenue rises, losses narrow on Nordic market share gains